LARGE SCALE BIOLOGY CORP
S-1/A, EX-27.1, 2000-07-24
PHARMACEUTICAL PREPARATIONS
Previous: LARGE SCALE BIOLOGY CORP, S-1/A, EX-23.4, 2000-07-24
Next: VERMONT WITCH HAZEL CO, SB-2, 2000-07-24



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS AND NOTES THERETO INCLUDED IN THE COMPANY'S REGISTRATION
STATEMENT ON FORM S-1 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
REGISTRATION STATEMENT ON FORM S-1.
</LEGEND>

<S>                           <C>                        <C>
<PERIOD-TYPE>                 YEAR                       6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-2000
<PERIOD-START>                             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               DEC-31-1999             JUN-30-2000
<CASH>                                       6,975,000               6,299,000
<SECURITIES>                                 7,124,000                       0
<RECEIVABLES>                                  141,000                 231,000
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                            15,216,000               8,903,000
<PP&E>                                      14,755,000              16,371,000
<DEPRECIATION>                             (5,251,000)             (6,902,000)
<TOTAL-ASSETS>                              31,762,000              24,750,000
<CURRENT-LIABILITIES>                       16,730,000              17,618,000
<BONDS>                                              0                       0
                                0                       0
                                 40,497,000              40,497,000
<COMMON>                                    39,469,000              39,827,000
<OTHER-SE>                                (86,669,000)            (88,722,000)
<TOTAL-LIABILITY-AND-EQUITY>                31,762,000              24,750,000
<SALES>                                              0                       0
<TOTAL-REVENUES>                            16,090,000              11,233,000
<CGS>                                                0                       0
<TOTAL-COSTS>                               46,892,000              15,322,000
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                           (34,705,000)             (3,376,000)
<INCOME-TAX>                                   190,000                       0
<INCOME-CONTINUING>                       (34,895,000)             (3,376,000)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                              (34,895,000)             (3,376,000)
<EPS-BASIC>                                     (2.01)                  (0.19)
<EPS-DILUTED>                                   (2.01)                  (0.19)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission